Position in AMGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,190,463
+$66,697 QoQ
Shares Held
6,049
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,234
of 3,140 holders
Holding Since
Mar 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HARBOR CAPITAL ADVISORS, INC. holds $35,051,660 across 8 Drug Manufacturers - General names. AMGN ranks #6 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,271 | $12,319,346 | |
| 2 | JNJ |
Johnson & Johnson
|
28,172 | $7,154,842 | |
| 3 | ABBV |
AbbVie Inc.
|
20,794 | $5,232,602 | |
| 4 | MRK |
Merck & Co., Inc.
|
27,785 | $3,570,372 | |
| 5 | OGN |
Organon & Co.
|
214,639 | $2,906,212 | |
| 6 | AMGN |
Amgen Inc
This page
|
6,049 | $2,190,463 | |
| 7 | PFE |
Pfizer Inc
|
66,351 | $1,597,732 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,390 | $80,091 |
All Filings in AMGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,190,463 | 6,049 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,123,766 | 6,036 | Shares | Sole | 2026-04-28 | |
| 2024-12-31 | $3,052,615 | 11,712 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $3,681,893 | 11,427 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $3,553,493 | 11,373 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $3,227,316 | 11,351 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,771,328 | 9,622 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $2,589,502 | 9,635 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $2,139,162 | 9,635 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $2,329,261 | 9,635 | Shares | Sole | 2023-04-26 | |
| No filing history on record for this holder in this stock. | ||||||